Millions more Americans are now eligible for insurance coverage for Kerecis’ medical-fish-skin technology. Many U.S. private insurers recently rated Kerecis MariGen as “medically necessary” for diabetic foot ulcers that have not healed with standard therapy.
As a result, several private insurance companies have decided to cover the Kerecis fish-skin technology, in addition to previously existing Medicare coverage. This milestone means that approximately 150 million Americans — around 45% of the country’s population — can now enjoy the benefits of the patented fish-skin treatment.
Kerecis MariGen now has commercial coverage for Diabetic Foot Ulcers from the following commercial payers:
• Anthem BCBS and its affiliated plans
• Amerigroup Real Solutions
• BCBS Georgia
• BCBS Minnesota
• BlueChoice HealthPlan of South Carolina
• Empire BCBS
• Simply Healthcare
Anthem BCBS and its affiliated plans cover 46.8 million lives
Not Healthcare Advice
This Site is not intended to provide diagnosis, treatment or medical advice. Products, services, information and other content provided on this Site, including information that may be provided on this Site directly or by linking to third-party websites, are provided for informational purposes only. Information on this Site should not be considered as a substitute for advice from a healthcare professional. Please consult with a physician or other healthcare professional regarding any medical or health related diagnosis or treatment options.
Products are not available in all countries and may be known by different names than used on this webpage. Products, product names, indications and claims vary between countries. Always make sure to check with your local health care professional and read the actual printed package information prior to use. Information on this website might not be current and might not be an accurate reflection of current product labeling.